Legal & General Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-70,159
| Closed | -$866K | – | 3401 |
|
|
2024
Q4 | $866K | Buy |
70,159
+8,635
| +14% | +$98.9K | ﹤0.01% | 2291 |
|
|
2024
Q3 | $700K | Buy |
61,524
+5,199
| +9% | +$52.2K | ﹤0.01% | 2352 |
|
|
2024
Q2 | $402K | Sell |
56,325
-1,602
| -3% | -$12.3K | ﹤0.01% | 2491 |
|
|
2024
Q1 | $388K | Hold |
57,927
| – | – | ﹤0.01% | 2527 |
|
|
2023
Q4 | $377K | Sell |
57,927
-112,969
| -66% | -$728K | ﹤0.01% | 2560 |
|
|
2023
Q3 | $1.61M | Sell |
170,896
-7,243
| -4% | -$87.2K | ﹤0.01% | 1988 |
|
|
2023
Q2 | $2.49M | Buy |
178,139
+21,558
| +14% | +$367K | ﹤0.01% | 1823 |
|
|
2023
Q1 | $2.94M | Buy |
156,581
+5,123
| +3% | +$84.2K | ﹤0.01% | 1695 |
|
|
2022
Q4 | $2.09M | Buy |
151,458
+4,717
| +3% | +$72.2K | ﹤0.01% | 1866 |
|
|
2022
Q3 | $2.81M | Sell |
146,741
-36
| -0% | -$656 | ﹤0.01% | 1677 |
|
|
2022
Q2 | $2.24M | Buy |
146,777
+1,479
| +1% | +$21.9K | ﹤0.01% | 1836 |
|
|
2022
Q1 | $2.96M | Sell |
145,298
-1,419
| -1% | -$28.9K | ﹤0.01% | 1803 |
|
|
2021
Q4 | $4.28M | Buy |
146,717
+124,477
| +560% | +$3.56M | ﹤0.01% | 1659 |
|
|
2021
Q3 | $480K | Buy |
22,240
+11,960
| +116% | +$289K | ﹤0.01% | 2418 |
|
|
2021
Q2 | $264K | Buy |
10,280
+3,815
| +59% | +$81.5K | ﹤0.01% | 2472 |
|
|
2021
Q1 | $118K | Buy |
6,465
+49
| +0.8% | +$814 | ﹤0.01% | 2573 |
|
|
2020
Q4 | $74K | Sell |
6,416
-334
| -5% | -$3.05K | ﹤0.01% | 2674 |
|
|
2020
Q3 | $51K | Sell |
6,750
-2,527
| -27% | -$19.1K | ﹤0.01% | 2693 |
|
|
2020
Q2 | $61K | Sell |
9,277
-61
| -0.7% | -$341 | ﹤0.01% | 2678 |
|
|
2020
Q1 | $48K | Sell |
9,338
-2,259
| -19% | -$13.7K | ﹤0.01% | 2607 |
|
|
2019
Q4 | $89K | Buy |
11,597
+1,968
| +20% | +$11.5K | ﹤0.01% | 2630 |
|
|
2019
Q3 | $51K | Hold |
9,629
| – | – | ﹤0.01% | 2728 |
|
|
2019
Q2 | $54K | Buy |
9,629
+2,067
| +27% | +$8.52K | ﹤0.01% | 2750 |
|
|
2019
Q1 | $32K | Hold |
7,562
| – | – | ﹤0.01% | 2905 |
|
|
2018
Q4 | $31K | Hold |
7,562
| – | – | ﹤0.01% | 2892 |
|
|
2018
Q3 | $52K | Hold |
7,562
| – | – | ﹤0.01% | 2753 |
|
|
2018
Q2 | $30K | Buy |
+7,562
| New | +$26.2K | ﹤0.01% | 3027 |
|
|
2016
Q2 | – | Sell |
-4,940
| Closed | -$15K | – | 2929 |
|
|
2016
Q1 | $15K | Hold |
4,940
| – | – | ﹤0.01% | 2710 |
|
|
2015
Q4 | $41K | Hold |
4,940
| – | – | ﹤0.01% | 2546 |
|
|
2015
Q3 | $35K | Hold |
4,940
| – | – | ﹤0.01% | 2607 |
|
|
2015
Q2 | $45K | Hold |
4,940
| – | – | ﹤0.01% | 2587 |
|
|
2015
Q1 | $47K | Hold |
4,940
| – | – | ﹤0.01% | 2530 |
|
|
2014
Q4 | $49K | Hold |
4,940
| – | – | ﹤0.01% | 2444 |
|
|
2014
Q3 | $48K | Buy |
+4,940
| New | +$55.3K | ﹤0.01% | 2404 |
|
Other funds holding CDMO
Legal & General Group's CDMO Position: Q1 2025 in Review
Legal & General Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 70,159 shares — an estimated $866K sold.
Legal & General Group first reported a position in CDMO in Q3 2014 and held it in 34 quarters. The position peaked at $4.28M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Legal & General Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Legal & General Group sold 70,159 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $866K.
- Legal & General Group first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2014 and held it in 34 quarters.
- Legal & General Group's Avid Bioservices, Inc. Common Stock position peaked at $4.28M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Legal & General Group's 13F filing for Q1 2025, filed 15 May 2025.